A multi-institutional study found that serially testing tumor samples can detect immune system activation in recurrent glioblastoma even when traditional imaging measures cannot. The researchers used multi-omic analysis and integrated data from various sources to show positive changes in the tumor microenvironment over time.
SourceMass General Brigham·JournalScience Translational Medicine·TypeExperimental study·DateOct 8, 2025
A team at Lund University has discovered a surface protein, SLAMF6, that helps leukemia cells evade the immune system. The researchers developed an antibody to block this mechanism, restoring the immune system's ability to kill cancer cells in laboratory trials and mice.
SourceLund University·JournalNature Cancer·TypeExperimental study·DateOct 3, 2025
Researchers at Johns Hopkins University discovered a novel way to boost the natural immune system, which prevents cancer recurrence and improves survival rates. The study used immune-activating agents to stimulate killer T cells and induce the formation of tumor-specific IgG antibodies.
SourceJohns Hopkins Medicine·JournalNature Immunology·DateSep 30, 2025
Scientists have created a high-potency IRE1 inhibitor with a unique inhibition mode that targets the unfolded protein response in cancer cells. This compound binds to the kinase pocket of IRE1, allosterically suppressing its RNAse activity and restoring proper protein folding.
SourceMax Planck Institute of Molecular Physiology·JournalNature Communications·DateSep 29, 2025
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center identify IGF2BP3 as a master switch linking cancer metabolism and RNA regulation in leukemia cells. The protein shifts energy breakdown and RNA modifications to support cell survival and multiplication.
SourceUniversity of California - Los Angeles Health Sciences·JournalCell Reports Medicine·DateSep 26, 2025
A joint team from The University of Osaka revealed that soft particles exhibit unique focusing patterns compared to rigid particles, influencing their focusing behavior. The study provides fundamental insights into the underlying physics, offering a new theoretical model explaining particle behavior under various flow regimes.
SourceThe University of Osaka·JournalJournal of Fluid Mechanics·TypeComputational simulation/modeling·DateSep 21, 2025
Researchers have discovered how Fusobacterium nucleatum binds to human cell receptors CEACAM1 and CEACAM5, which are frequently overexpressed on many types of cancer cells. This binding mechanism is crucial for developing novel antitumor therapies.
SourceChinese Academy of Sciences Headquarters·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 19, 2025
Researchers at Graz University of Technology created a highly detailed digital twin of the A549 lung cancer cell line, paving the way for individualized cancer treatment. The model simulates calcium dynamics and electrical voltages, allowing for testing of drugs and personalized treatment strategies.
SourceGraz University of Technology·JournalClinical and Translational Medicine·TypeComputational simulation/modeling·DateSep 18, 2025
Researchers found that glioblastoma cells in clusters are less deadly than those that disperse from these clusters. The dispersed cells are more plastic and resistant to therapy, making them a major contributor to treatment resistance and poor patient outcomes.
SourceUniversity of Miami Miller School of Medicine·JournalCancer Cell·DateSep 18, 2025
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Researchers at Salk Institute and UC San Diego have identified a unique sugar called HSAT as a potential therapeutic target for slowing tumor progression and metastasis in pancreatic ductal adenocarcinoma. Boosting HSAT levels may slow the formation and spread of pancreatic cancer, leading to improved survival rates among patients.
SourceSalk Institute·JournalJournal of Clinical Investigation·DateSep 17, 2025
Scientists used long-read whole-genome sequencing to analyze methylation patterns in urine DNA, identifying bladder cancer. The approach outperformed existing tests in detecting cancer even at low tumour DNA levels.
SourceUniversity of Birmingham·JournalClinical Epigenetics·TypeExperimental study·DateSep 17, 2025
Armida Labs will use the funding to advance preclinical studies of Targefrin, a potential clinical candidate for pancreatic and other cancers. The grant aims to develop an anti-metastatic agent that targets the EphA2 protein, which drives cancer cell invasion and metastasis.
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
A team of Japanese researchers has identified shootin1b as a protein that promotes cell migration in glioblastoma, the most common and difficult-to-treat brain tumor. By suppressing abnormal activity of shootin1b, the study suggests a potential target for preventing glioblastoma spread.
SourceNara Institute of Science and Technology·JournalAdvanced Science·TypeExperimental study·DateSep 11, 2025
A new computational tool called scODIN simplifies single-cell analysis by automating cell type identification in scRNA-seq data. It allows users to define specific cell subsets at different levels of detail and recognizes cells with intermediate phenotypes or transitional states, capturing complexity missed by traditional methods.
SourceThe University of Osaka·JournalThe Journal of Immunology·TypeExperimental study·DateSep 10, 2025
A clinical trial found that patients with mesothelioma who received combination immunotherapy drugs before surgery had successful surgeries and improved early outcomes. The study showed that tracking tumor DNA in the blood could help predict treatment benefit.
SourceTrinity College Dublin·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateSep 9, 2025
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A new study from Mizzou's College of Veterinary Medicine analyzed the effects of radioactive iodine therapy on thyroid cancer in dogs. The research found that tailoring the dose of radiation more precisely for each dog could improve outcomes and potentially lead to more targeted care.
SourceUniversity of Missouri-Columbia·JournalVeterinary and Comparative Oncology·DateSep 9, 2025
A new study demonstrates the safety and potential benefits of a perioperative combination immune checkpoint blockade in resectable mesothelioma. Patients treated with the regimen lived a median of 28.6 months, with nearly 36% alive and recurrence-free at follow-up.
SourceJohns Hopkins Medicine·JournalNature Medicine·DateSep 8, 2025
Researchers found a unique microbial signature in colorectal cancer samples that can accurately distinguish them from other types of cancer. This discovery has the potential to improve diagnosis and treatment outcomes for patients with colorectal cancer.
SourceUniversity of East Anglia·JournalScience Translational Medicine·TypeObservational study·DateSep 3, 2025
Researchers at SMART Alliance for Research and Technology developed a powerful tool to scan thousands of biological samples and detect transfer ribonucleic acid (tRNA) modifications, which help control cell growth and response to diseases. The tool opens up new possibilities for disease research, diagnostics, and treatment development.
SourceSingapore-MIT Alliance for Research and Technology (SMART)·JournalNucleic Acids Research·TypeExperimental study·DateSep 3, 2025
Scientists have found a way to stop brain cancer cells from spreading by 'freezing' hyaluronic acid molecules in place. This approach could lead to a new type of treatment for glioblastoma, the most aggressive form of brain cancer.
SourceUniversity of Cambridge·JournalRoyal Society Open Science·DateSep 2, 2025
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
Researchers discovered that disrupting protein quality control slows tumor growth in rhabdomyosarcoma, a rare and aggressive cancer primarily affecting children. The treatment, which targets the proteostasis network, significantly slowed or stopped tumor growth in mice implanted with human RMS tumors.
SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateAug 29, 2025
The foundation provides $300,000 total funding over four years to investigate cancer causes, mechanisms, therapies, and prevention. This support fosters interdisciplinary research and encourages innovative projects that push boundaries and make breakthroughs.
SourceDamon Runyon Cancer Research Foundation·DateAug 28, 2025
Researchers at Purdue University have developed a new method to study biochemical processes that impair the immune system's ability to recognize and kill cancer cells. The method involves tracking RNA-binding proteins and extracellular vesicles, which can compromise immunotherapy.
SourcePurdue University·JournalJournal of the American Chemical Society·DateAug 25, 2025
Researchers found that cancer cells break down nerve protective covers, triggering chronic inflammation and immune exhaustion, making treatment resistant. Targeting the nerve injury pathway can reverse this resistance and improve treatment response.
SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature·DateAug 20, 2025
A new study reveals that body cells change their shape to close gaps such as wounds, using a combination of crawling movements and 'purse-string' contractions. The researchers discovered that the endoplasmic reticulum's ability to reorganize in response to edge curvature plays a crucial role in epithelial cell movement.
SourceUniversity of Birmingham·JournalNature Cell Biology·TypeExperimental study·DateAug 18, 2025
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
The ARCHER study aims to determine whether ultra-hypofractionated stereotactic body radiation therapy is non-inferior to hypofractionated radiotherapy in preserving bladder function. Patients will be randomly assigned to receive either 4 weeks of daily or 5 days of ultra-hypofractionated SBRT.
A team of researchers developed a technology that allows them to measure millions of cell-to-cell interactions quickly and affordably. The study shows that this approach can help predict how patients will respond to immunotherapies, laying the foundation for more personalized treatments.
SourceMax Delbrück Center for Molecular Medicine in the Helmholtz Association·JournalNature Methods·TypeExperimental study·DateAug 7, 2025
Researchers developed a software fueled by genomics to predict cancer cell behavior, combining genomics technologies with computational modeling. The new 'grammar' enables communication between biology and code, allowing scientists to build digital representations of multicellular biological systems and simulate diseases like cancer.
SourceUniversity of Maryland School of Medicine·JournalCell·TypeComputational simulation/modeling·DateJul 25, 2025
Research at University of Arizona Health Sciences found PFAS exposure affects gene activity, tied to cancers, neurological disorders, and autoimmune conditions. Changes in miRNA activity indicate potential health risks, suggesting a link between environmental exposures and disease.
SourceUniversity of Arizona Health Sciences·JournalEnvironmental Research·TypeData/statistical analysis·DateJul 24, 2025
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers at Fralin Biomedical Research Institute have identified a potential target for experimental drugs that block PRMT5, a naturally occurring enzyme some tumors rely on for survival. The study found a new drug combination that works against certain hard-to-treat cancers.
Researchers found that radiation plus immunotherapy induces a systemic anti-tumor immune response in non-small cell lung cancer, even in tumors that do not typically respond to immunotherapy. The combination therapy improved clinical response in patients whose tumors harbor features of immunotherapy resistance.
SourceJohns Hopkins Medicine·JournalNature Cancer·DateJul 22, 2025
Scientists developed a material that can stick to tumors, pumping out chemotherapy drugs for days, minimizing impact on healthy tissue. Early results show great promise for reducing clinical treatments and improving patient outcomes.
SourceUniversity of Colorado at Boulder·JournalAdvanced Materials·TypeExperimental study·DateJul 21, 2025
A new study published in JAMA Network Open found no statistical relationship between pathologic complete response (pCR) and overall survival in rectal cancer patients. This challenges the FDA's use of pCR as a surrogate endpoint for drug approval, which may lead to treatments being fast-tracked without evidence of improved long-term su...
SourceTulane University·JournalJAMA Network Open·DateJul 17, 2025
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
A team led by University of Houston engineer Tianfu Wu aims to find better biomarkers for ovarian cancer using autoantibodies and machine learning. By detecting ovarian cancer earlier, mortality rates could be reduced by 10-30%.
Researchers developed OmicsTweezer, a tool that uses machine learning and single-cell data integration to analyze human tissue. The tool can estimate cell type composition in tumors and surrounding tissues, which could help pinpoint potential therapeutic targets.
SourceOregon Health & Science University·JournalCell Genomics·DateJul 16, 2025
Researchers at Emory University have discovered that psilocybin can delay cellular aging by over 50% and extend the lifespan of human skin and lung cells. In a study involving aged mice, psilocybin was shown to increase survival by 30% and improve physical features, suggesting potential for anti-aging therapies.
SourceEmory Health Sciences·Journalnpj Aging·TypeExperimental study·DateJul 9, 2025
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Gene coexpression analysis reveals optimal markers of cell types and states, providing opportunities for developing novel biomarkers and targeted treatment strategies for glioma patients. Dr. Oldham's work tackles the reproducibility crisis in science, emphasizing data metadata standardization.
SourceGenomic Press·JournalBrain Medicine·TypeNews article·DateJul 8, 2025
A novel fluorescent probe, SLY, has been developed to precisely identify hepatocellular carcinoma tissue using sialylated glycans on the cell surface. The probe outperforms conventional methods by clearly distinguishing tumor margins within liver tissues.
SourcePohang University of Science & Technology (POSTECH)·JournalJournal of the American Chemical Society·DateJul 6, 2025
A study by Arc Institute and Stanford University scientists reveals that the target site of a popular STING inhibitor lacks a pocket found in mouse STING, making it challenging to develop effective human treatments. The research proposes targeting STING by preventing oligomerization, a key checkpoint prior to activation.
SourceArc Institute·JournalNature Chemical Biology·TypeExperimental study·DateJul 3, 2025
Researchers have identified a single genetic difference in Fas Ligand, an immune protein, that makes it vulnerable to being disabled by plasmin, a tumor-associated enzyme. This vulnerability seems unique to humans and may contribute to the effectiveness of certain cancer treatments.
SourceUniversity of California - Davis Health·JournalNature Communications·TypeExperimental study·DateJul 2, 2025
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
Scientists at Nagoya University discovered that dying cancer cells can trigger an inflammatory feedback loop that promotes tumor growth. When macrophages consume dying cancer cells, they produce cytokines that activate growth signals in remaining cancer cells.
SourceNagoya University·JournalCurrent Biology·TypeExperimental study·DateJun 25, 2025
Researchers developed an AI tool called AAnet to characterize cancer cell diversity, identifying five distinct cell groups with different gene expression profiles. This could lead to more targeted therapies and improved patient outcomes.
SourceGarvan Institute of Medical Research·JournalCancer Discovery·TypeExperimental study·DateJun 24, 2025
Researchers from Université Libre de Bruxelles discovered inflammation-induced cellular reprogramming leading to tumor initiation. They found that this process occurs differently in various regions of the prostate, with severe cases associated with more aggressive cancers.
SourceUniversité libre de Bruxelles·JournalNature Cancer·DateJun 23, 2025
Researchers discovered dynamic cells coordinate movements to sculpt living tissue in developing fruit flies, highlighting a powerful role of migrating cells in organ formation. This finding suggests similar systems may shape different organs, including the brain and testis.
SourceUniversity of North Carolina at Chapel Hill·JournalScience Advances·DateJun 18, 2025
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Researchers at Nagoya University have created CAR-T cells that recognize and target the Eva1 protein on cancer cells, effectively eliminating tumors in lab mice. The treatment is designed to be safer by ignoring healthy cells with low amounts of Eva1.
SourceNagoya University·JournalJournal for ImmunoTherapy of Cancer·TypeExperimental study·DateJun 10, 2025
A pilot study found that exercising during chemotherapy can increase the number of immune cells fighting cancer, including CD8+ T cells and natural killer cells. The exercise programme improved patients' aerobic fitness, leading to stronger immune responses inside tumours.
SourceUniversity of Surrey·JournalJournal of Sport and Health Science·DateJun 9, 2025
Researchers identified a novel region in AR that binds to PCNA, and developed a small peptide to mimic this region, blocking the AR-PCNA connection. This approach reduced cancer cell growth, particularly in patients with limited treatment options.
SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateJun 4, 2025
Researchers at Ben-Gurion University of the Negev have made a breakthrough in harnessing patient's own T-cells to fight off cancer by creating artificial surfaces mimicking natural immune cells. These surfaces, engineered with nanostructures, strengthen and prolong activation of T-cells, leading to more effective immunotherapy.
SourceBen-Gurion University of the Negev·JournalAdvanced Materials·TypeExperimental study·DateJun 4, 2025
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Cancer cells and immune cells without the Y chromosome tend to have poorer outcomes, making them more aggressive. Researchers hope to adapt therapies to account for this loss to improve treatment effectiveness.
SourceCedars-Sinai Medical Center·JournalNature·DateJun 4, 2025
Researchers discovered a specialized histone arrangement, called the CENP-A–H4 octasome, in centromeric regions. This unique structure likely contributes to proper kinetochore formation and mitosis.
SourceInstitute of Science Tokyo·JournalGenes to Cells·TypeExperimental study·DateMay 30, 2025
Researchers developed a 3D in vitro culture system to study tumor cell behavior, finding that clusters can infiltrate blood vessels by disrupting the endothelial barrier. This discovery suggests new targets for cancer treatment strategies.
SourceInstitute of Industrial Science, The University of Tokyo·JournaliScience·DateMay 22, 2025
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
A UCLA study found that selective serotonin reuptake inhibitors (SSRIs) can significantly enhance the ability of T cells to fight cancer and suppress tumor growth across various cancer types in mouse and human tumor models. SSRIs increased access to serotonin signals, making killer T cells happier and more effective at killing cancer c...
SourceUniversity of California - Los Angeles Health Sciences·JournalCell·DateMay 21, 2025
Researchers developed an artificial intelligence technique that detects DNA fragments in patient blood to monitor treatment response. The ARTEMIS-DELFI approach was found to be more effective and simpler than existing methods, allowing for quicker identification of patients who are not responding to therapy.
SourceJohns Hopkins Medicine·JournalScience Advances·DateMay 21, 2025
Researchers at MIT developed a method to quickly measure cell density, which can predict whether immunotherapies will work in patients or how tumors will respond to drug treatment. The technique uses a combined microfluidic device and fluorescent microscope to measure up to 30,000 cells in an hour.
SourceMassachusetts Institute of Technology·JournalNature Biomedical Engineering·DateMay 20, 2025
Dr. Britta Will has been appointed as the permanent director of the Ruth L. and David S. Gottesman Institute, succeeding Ulrich Steidl. Her research focuses on restoring blood regeneration in older adults and those with cancer. She aims to advance fundamental research into stem cell function and tissue regeneration to combat chronic de...
A study led by Johns Hopkins Medicine scientists found that rearranged genes in a rare type of kidney cancer form liquid droplets that turn on cancer-promoting genes. By disrupting these droplets, researchers may develop new therapies for this currently untreatable cancer.
SourceJohns Hopkins Medicine·JournalCell Reports·DateMay 15, 2025
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
The University of Texas at Arlington's nursing and physics team has developed a system to study alpha radiation, improving the effectiveness of radiation therapy. The team's research was recognized with the Best in Physics award at the American Association of Physicists in Medicine's annual meeting.
SourceUniversity of Texas at Arlington·TypeExperimental study·DateMay 12, 2025
Researchers developed a comprehensive cell line atlas to better understand the biology of advanced biliary tract cancer. The atlas identifies new molecular subtypes and therapeutic targets, offering a path toward more tailored treatment strategies.
SourceMass General Brigham·JournalCancer Discovery·DateMay 12, 2025
Researchers at MD Anderson Cancer Center have made breakthroughs in understanding pancreatic cancer metastases and identifying potential biomarkers for treatment-resistant pancreatic cancer. A comprehensive spatial map provides insights into lineage shifts in cancer cells transitioning from primary tumors to organ-specific metastases.
SourceUniversity of Texas M. D. Anderson Cancer Center·DateMay 8, 2025
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
Researchers from the University of Southampton engineered a new type of super-strong antibody that triggers a stronger response from the immune system compared to naturally produced antibodies. The study confirms that making subtle increases in rigidity stimulates immune activity, creating a powerful immune response against disease.
SourceUniversity of Southampton·JournalNature Communications·TypeExperimental study·DateMay 1, 2025